BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 2525260)

  • 21. Glucose regulated protein induction and cellular resistance to oxidative stress mediated by porphyrin photosensitization.
    Gomer CJ; Ferrario A; Rucker N; Wong S; Lee AS
    Cancer Res; 1991 Dec; 51(24):6574-9. PubMed ID: 1835901
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Resistance to photodynamic therapy in radiation induced fibrosarcoma-1 and Chinese hamster ovary-multi-drug resistant. Cells in vitro.
    Singh G; Wilson BC; Sharkey SM; Browman GP; Deschamps P
    Photochem Photobiol; 1991 Aug; 54(2):307-12. PubMed ID: 1838198
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Implications of a pre-existing tumor hypoxic fraction on photodynamic therapy.
    Fingar VH; Wieman TJ; Park YJ; Henderson BW
    J Surg Res; 1992 Nov; 53(5):524-8. PubMed ID: 1434604
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of photofrin II and light energy on retinoblastoma-like cells in vitro. Dose-response relationships, effect of light dose rate and recovery ratio.
    Winther J
    J Cancer Res Clin Oncol; 1989; 115(1):73-8. PubMed ID: 2522095
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evidence for different mechanisms of EMT-6 tumor necrosis by photodynamic therapy with disulfonated aluminum phthalocyanine or photofrin: tumor cell survival and blood flow.
    Chan WS; Brasseur N; La Madeleine C; van Lier JE
    Anticancer Res; 1996; 16(4A):1887-92. PubMed ID: 8712717
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment with the tumor necrosis factor-alpha-inducing drug 5,6-dimethylxanthenone-4-acetic acid enhances the antitumor activity of the photodynamic therapy of RIF-1 mouse tumors.
    Bellnier DA; Gollnick SO; Camacho SH; Greco WR; Cheney RT
    Cancer Res; 2003 Nov; 63(22):7584-90. PubMed ID: 14633671
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Photodynamic therapy of murine skin tumors using Photofrin-II.
    Mukhtar H; Agarwal R; Athar M; Lewen RL; Elmets CA; Bickers DR
    Photodermatol Photoimmunol Photomed; 1991 Aug; 8(4):169-75. PubMed ID: 1839955
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cell survival characteristics of a human colon adenocarcinoma cell line after photodynamic treatment: a comparison of Photofrin II and TPPS.
    West CM; Moore JV
    Int J Radiat Biol; 1988 Oct; 54(4):621-34. PubMed ID: 2902160
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mitochondrial alterations in photodynamic therapy-resistant cells.
    Sharkey SM; Wilson BC; Moorehead R; Singh G
    Cancer Res; 1993 Oct; 53(20):4994-9. PubMed ID: 8402690
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modification of photodynamic therapy-induced hypoxia by fluosol-DA (20%) and carbogen breathing in mice.
    Fingar VH; Mang TS; Henderson BW
    Cancer Res; 1988 Jun; 48(12):3350-4. PubMed ID: 3130983
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Photodynamic therapy with verteporfin in the radiation-induced fibrosarcoma-1 tumor causes enhanced radiation sensitivity.
    Pogue BW; O'Hara JA; Demidenko E; Wilmot CM; Goodwin IA; Chen B; Swartz HM; Hasan T
    Cancer Res; 2003 Mar; 63(5):1025-33. PubMed ID: 12615718
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changes in tumor interstitial pressure induced by photodynamic therapy.
    Fingar VH; Wieman TJ; Doak KW
    Photochem Photobiol; 1991 Jun; 53(6):763-8. PubMed ID: 1832229
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Explicit dosimetry for photodynamic therapy: macroscopic singlet oxygen modeling.
    Wang KK; Finlay JC; Busch TM; Hahn SM; Zhu TC
    J Biophotonics; 2010 Jun; 3(5-6):304-18. PubMed ID: 20222102
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro photodynamic treatment of normal and human papilloma virus-transfected keratinocytes with photofrin II and red light.
    Bernstein EF; Glass JM; DeGraff WG; Schlegel R; Black C; Fisher JM; Cook SN; Glatstein E; Russo A; Mitchell JB
    Arch Dermatol; 1991 May; 127(5):683-7. PubMed ID: 1850973
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oxygen dependency of tumor cell killing in vitro by light-activated Photofrin II.
    Chapman JD; Stobbe CC; Arnfield MR; Santus R; Lee J; McPhee MS
    Radiat Res; 1991 Apr; 126(1):73-9. PubMed ID: 1826959
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Investigation of cross-resistance to a range of photosensitizers, hyperthermia and UV light in two radiation-induced fibrosarcoma cell strains resistant to photodynamic therapy in vitro.
    Mayhew S; Vernon DI; Schofield J; Griffiths J; Brown SB
    Photochem Photobiol; 2001 Jan; 73(1):39-46. PubMed ID: 11202364
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Photofrin
    Baran TM
    Lasers Surg Med; 2018 Jul; 50(5):476-482. PubMed ID: 29214668
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Photodynamic therapy effect in an intraocular retinoblastoma-like tumour assessed by an in vivo to in vitro colony forming assay.
    Winther J
    Br J Cancer; 1989 Jun; 59(6):869-72. PubMed ID: 2525401
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel photodynamic effects of a benzophenothiazine on two different murine sarcomas.
    Cincotta L; Foley JW; MacEachern T; Lampros E; Cincotta AH
    Cancer Res; 1994 Mar; 54(5):1249-58. PubMed ID: 8118813
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Photodynamic therapy-mediated oxidative stress can induce expression of heat shock proteins.
    Gomer CJ; Ryter SW; Ferrario A; Rucker N; Wong S; Fisher AM
    Cancer Res; 1996 May; 56(10):2355-60. PubMed ID: 8625311
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.